CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
Oidov Baatarkhuu, Jae Seung Lee, Jazag Amarsanaa, Do Young Kim, Sang Hoon Ahn, Nyamsuren Naranzul, Damba Enkhtuya, Nagir Choijamts, Purev Batbayar, Radnaa Otgonbayar, Bat-Ulzii Saruul, Chuluunbaatar Gantuul, Baljinnyam Gegeebadrakh, Narangerel Tuvshinbayar, Dorjgotov Badamsuren, Galsan Ulzmaa, Jamiyandorj Otgonbold, Kwang-Hyub Han
Clin Mol Hepatol. 2021;27(1):125-135.   Published online 2020 November 27    DOI: https://doi.org/10.3350/cmh.2020.0023

Excel Download

Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
Clinical and Molecular Hepatology. 2021;27(1):125-135   Crossref logo
Link1 Link2 Link3

P1-071: Efficacy of Ledipasvir/Sofosbuvir in Egyptian adolescents with hepatitis C virus genotype 4; a single center study
Journal of Viral Hepatitis. 2018;25:59-59   Crossref logo
Link1 Link2

Efficacy and Safety of Ledipasvir/Sofosbuvir with and without Ribavirin in Patients with Chronic Hepatitis C Virus Genotype 1 Infection: a meta-analysis
International Journal of Infectious Diseases. 2017;55:56-71   Crossref logo
Link1 Link2

Ledipasvir/Sofosbuvir versus Daclatasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Genotype 4 Patients
Current Drug Safety. 2020;15(1):53-60   Crossref logo
Link1

THU-113-Comparison between safety and efficacy of two treatment regimens for pediatric patients with chronic hepatitis C virus: Sofosbuvir/ledipasvir versus sofosbuvir/daclatasvir regimen
Journal of Hepatology. 2019;70(1):e208   Crossref logo
Link1 Link2

Safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in hepatitis C genotype 1 patients including those with decompensated cirrhosis who failed prior treatment with simeprevir/sofosbuvir
Alimentary Pharmacology & Therapeutics. 2018;47(10):1409-1415   Crossref logo
Link1 Link2

Effectiveness of Ledipasvir/Sofosbuvir for Hepatitis C Virus (HCV) Treatment Among HIV-Infected Patients: A Community Hospital Experience
Open Forum Infectious Diseases. 2016;3(suppl_1):   Crossref logo
Link1

Ledipasvir/sofosbuvir
Reactions Weekly. 2018;1722(1):202-202   Crossref logo
Link1 Link2 Link3

Role of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infection
Hepatic Medicine: Evidence and Research. 2016;Volume 8:75-80   Crossref logo
Link1

Su1440 Multicenter Study Evaluating Prevalence of Genotypic Resistance-Associated Variants of Hepatitis C Virus Genotype 1 in Ledipasvir/Sofosbuvir Relapsers
Gastroenterology. 2016;150(4):S1100   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.